IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease.
Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, Genrich K, Mehrotra S, Setty S, Smith B, et al. Eur J Immunol. 2008 Jun; 38(6):1745-55.